Applied Precision Introduces Personal Deltavision and its Next-Generation Deltavision Core
News Dec 27, 2006
Applied Precision has announced the expansion of its restoration imaging series, DeltaVision®, with the PersonalDV and DeltaVision Core systems.
According to the Applied Precision, the PersonalDV and the DeltaVision Core are set to enable high-resolution, high-throughput experimentation for research and drug discovery, and is aiming to address two market needs: an imaging system for fixed- and live-cell imaging and a high-powered imaging system able to extend live-cell performance and manage high-volume data generation.
DeltaVision RT can utilize a quality imaging and high-performance capabilities from its predecessor, the PersonalDV is a smaller, system developed for individual academic research labs and biotech startups.
Addressing higher-end market needs for imaging cell kinetics, DeltaVision Core is the company's next breakthrough for high-resolution, multi-dimensional, live-cell imaging.
DeltaVision Core can enable increased probes, multiple fields of view, expanded data acquisition as well as increased storage and computing capacity to speed time to discovery.
The DeltaVision Core is equipped to handle extensive time course experiments-over 1,000 hours of continuous imaging-and features capabilities including multiplexed wavelengths, faster channel imaging and acquisition, large-travel stage, server class computation, and data management solutions.
"We're taking the DeltaVision platform to new heights to address both the economic and superior performance requirements of drug discovery and systems biology," said Applied Precision's senior product manager and technical fellow, Paul Goodwin.
"With the PersonalDV, we're broadening our market focus to provide DeltaVision's high-quality imaging capabilities for budget-conscious and footprint-limited labs. All the while, there's an ever-increasing need for optimized live-cell imaging performance with the capacity to handle a tremendous volume of data acquisition, which fueled the development of DeltaVision Core."
"We are extremely enthusiastic to offer these new products on our proven DeltaVision platform and specifically eager to provide access to the DeltaVision technology to a wider audience via the PersonalDV," added Applied Precision's Sr. Vice President of Life Sciences, Joseph Victor.
The DeltaVision platform offers real-time restoration imaging for microscopy. Chief among its features are its high-quality images, extended live-cell viability and superior mechanical precision.
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.